02_CD GlaxoSmithKline_NNP Financial_NNP summary_NN 2001_CD 2002_CD restated_VBN Increase_VBP Statutory_JJ results_NNS m_VBP m_JJ %_NN CER_CD %_NN Sales_NNS 21,212_CD 20,489_CD 4_CD 7_CD Trading_NN profit_NN 5,662_CD 4,697_CD 21_CD 26_CD profit_NN before_IN taxation_NN 5,506_CD 4,517_CD 22_CD 28_CD Earnings_NNS Net_JJ income_NN 3,915_CD 3,053_CD 28_CD 35_CD Basic_JJ earnings_NNS per_IN share_NN 66.2_CD p_NN 50.3_CD p_NN 32_CD 38_CD Dividends_NNS per_IN share_NN 40.0_CD p_VBP 39.0_CD p_JJ Merger_NNP ,_, restructuring_NN and_CC disposal_NN of_IN subsidiaries_NNS Trading_NN profit_NN 1,032_CD 1,356_CD profit_NN before_IN taxation_NN 1,011_CD 1,652_CD Earnings_NNS Net_JJ income_NN 712_CD 1,330_CD Business_NN performance_NN Sales_NNS 21,212_CD 20,489_CD 4_CD 7_CD Trading_NN profit_NN 6,694_CD 6,053_CD 11_CD 15_CD profit_NN before_IN taxation_NN 6,517_CD 6,169_CD 6_CD 11_CD Adjusted_VBN earnings_NNS Net_JJ income_NN 4,627_CD 4,383_CD 6_CD 11_CD Adjusted_VBN earnings_NNS per_IN share_NN 78.3_CD p_NN 72.3_CD p_NN 8_CD 13_CD Business_NN performance_NN ,_, which_WDT is_VBZ the_DT primary_JJ performance_NN measure_NN used_VBN by_IN management_NN ,_, is_VBZ presented_VBN after_IN excluding_VBG merger_NN items_NNS ,_, integration_NN and_CC restructuring_NN costs_NNS and_CC the_DT disposal_NN of_IN businesses_NNS ._.
Management_NNP believes_VBZ that_IN exclusion_NN of_IN these_DT non-recurring_JJ items_NNS provides_VBZ a_DT better_JJR comparison_NN of_IN business_NN performance_NN for_IN the_DT periods_NNS presented_VBN ._.
Statutory_JJ results_NNS include_VBP these_DT non-recurring_JJ items_NNS ._.
This_DT information_NN is_VBZ provided_VBN as_IN a_DT supplement_NN to_TO that_DT included_VBN in_IN the_DT consolidated_JJ statement_NN of_IN profit_NN and_CC loss_NN on_IN pages_NNS 76_CD and_CC 77_CD prepared_JJ in_IN accordance_NN with_IN UK_NNP GAAP_NNP ._.
The_DT Group_NNP ,_, as_IN a_DT multinational_JJ business_NN ,_, operates_VBZ in_IN many_JJ countries_NNS and_CC earns_VBZ revenues_NNS and_CC incurs_VBZ costs_NNS in_IN many_JJ currencies_NNS ._.
The_DT results_NNS of_IN the_DT Group_NNP ,_, as_IN reported_VBN in_IN sterling_NN ,_, are_VBP therefore_RB affected_VBN by_IN movements_NNS in_IN exchange_NN rates_NNS between_IN sterling_NN and_CC overseas_JJ currencies_NNS ._.
The_DT Group_NNP uses_VBZ the_DT average_JJ exchange_NN rates_NNS prevailing_VBG during_IN the_DT year_NN to_TO translate_VB the_DT results_NNS of_IN overseas_JJ companies_NNS into_IN sterling_NN ._.
The_DT currencies_NNS which_WDT most_RBS inuence_JJ these_DT translations_NNS are_VBP the_DT US_NNP dollar_NN ,_, the_DT Euro_NNP and_CC the_DT Japanese_JJ Yen_NN ._.
During_IN 2002_CD average_JJ sterling_JJ exchange_NN rates_NNS were_VBD stronger_JJR against_IN the_DT US_NNP dollar_NN and_CC the_DT Japanese_JJ Yen_NN by_IN four_CD per_IN cent_NN and_CC seven_CD per_IN cent_NN ,_, respectively_RB ,_, and_CC weaker_JJR against_IN the_DT Euro_NNP by_IN one_CD per_IN cent_NN ,_, compared_VBN with_IN 2001_CD ._.
In_IN order_NN to_TO illustrate_VB underlying_VBG performance_NN ,_, it_PRP is_VBZ the_DT Groups_NNS practice_NN to_TO discuss_VB its_PRP$ results_NNS in_IN terms_NNS of_IN constant_JJ exchange_NN rate_NN CER_NNP growth_NN ._.
This_DT represents_VBZ growth_NN calculated_VBN as_IN if_IN the_DT exchange_NN rates_NNS used_VBN to_TO determine_VB the_DT results_NNS of_IN overseas_JJ companies_NNS in_IN sterling_NN had_VBD remained_VBN unchanged_JJ from_IN those_DT used_VBN in_IN the_DT previous_JJ year_NN ._.
The_DT discussion_NN in_IN this_DT report_NN is_VBZ therefore_RB in_IN terms_NNS of_IN CER_NNP unless_IN otherwise_RB stated_VBN ._.
%_NN represents_VBZ growth_NN at_IN actual_JJ exchange_NN rates_NNS ._.
CER_CD %_NN represents_VBZ growth_NN at_IN constant_JJ exchange_NN rates_NNS ._.
During_IN 2002_CD FRS_NNP 19_CD Deferred_JJ tax_NN has_VBZ been_VBN implemented_VBN by_IN the_DT Group_NNP ._.
This_DT FRS_NNP requires_VBZ deferred_JJ tax_NN to_TO be_VB accounted_VBN for_IN on_IN a_DT full_JJ provision_NN basis_NN ,_, rather_RB than_IN a_DT partial_JJ provision_NN basis_NN as_IN in_IN 2001_CD and_CC earlier_JJR years_NNS ._.
This_DT change_NN has_VBZ been_VBN accounted_VBN for_IN as_IN a_DT prior_JJ year_NN adjustment_NN and_CC comparative_JJ information_NN has_VBZ been_VBN restated_VBN as_RB necessary_JJ ._.
Cautionary_JJ statement_NN regarding_VBG forward-looking_JJ statements_NNS The_DT Group_NNP 's_POS reports_NNS led_VBD with_IN the_DT US_NNP Securities_NNPS and_CC Exchange_NNP Commission_NNP SEC_NNP ,_, including_VBG this_DT document_NN and_CC written_VBN information_NN released_VBN ,_, or_CC oral_JJ statements_NNS made_VBN ,_, to_TO the_DT public_NN in_IN the_DT future_NN by_IN or_CC on_IN behalf_NN of_IN the_DT Group_NNP ,_, may_MD contain_VB forward-looking_JJ statements_NNS ._.
Forward-looking_VBG statements_NNS give_VBP the_DT Group_NNP 's_POS current_JJ expectations_NNS or_CC forecasts_NNS of_IN future_JJ events_NNS ._.
An_DT investor_NN can_MD identify_VB these_DT statements_NNS by_IN the_DT fact_NN that_IN they_PRP do_VBP not_RB relate_VB strictly_RB to_TO historical_JJ or_CC current_JJ facts_NNS ._.
They_PRP use_VBP words_NNS such_JJ as_IN anticipate_VBP ,_, estimate_VBP ,_, expect_VBP ,_, intend_VBP ,_, will_MD ,_, project_NN ,_, plan_NN ,_, believe_VB and_CC other_JJ words_NNS and_CC terms_NNS of_IN similar_JJ meaning_NN in_IN connection_NN with_IN any_DT discussion_NN of_IN future_JJ operating_NN or_CC financial_JJ performance_NN ._.
In_IN particular_JJ ,_, these_DT include_VBP statements_NNS relating_VBG to_TO future_JJ actions_NNS ,_, prospective_JJ products_NNS or_CC product_NN approvals_NNS ,_, future_JJ performance_NN or_CC results_NNS of_IN current_JJ and_CC anticipated_JJ products_NNS ,_, sales_NNS efforts_NNS ,_, expenses_NNS ,_, the_DT outcome_NN of_IN contingencies_NNS such_JJ as_IN legal_JJ proceedings_NNS ,_, and_CC financial_JJ results_NNS ._.
The_DT Group_NNP undertakes_VBZ no_DT obligation_NN to_TO update_VB any_DT forward-looking_JJ statements_NNS ,_, whether_IN as_IN a_DT result_NN of_IN new_JJ information_NN ,_, future_JJ events_NNS or_CC otherwise_RB ._.
Forward-looking_VBG statements_NNS involve_VBP inherent_JJ risks_NNS and_CC uncertainties_NNS ._.
The_DT Group_NNP cautions_VBZ investors_NNS that_IN a_DT number_NN of_IN important_JJ factors_NNS including_VBG those_DT in_IN this_DT document_NN could_MD cause_VB actual_JJ results_NNS to_TO differ_VB materially_RB from_IN those_DT contained_VBN in_IN any_DT forward-looking_JJ statement_NN ._.
Such_JJ factors_NNS include_VBP ,_, but_CC are_VBP not_RB limited_VBN to_TO ,_, those_DT discussed_VBN under_IN Risk_NNP factors_NNS on_IN pages_NNS 64_CD and_CC 65_CD of_IN this_DT Annual_JJ Report_NNP ._.
